Who
Napoleone Ferrara
Director
Company insider
Files Form 4 as: Director, Kalaris Therapeutics; Director, TuHURA Biosciences.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 22 Jun 2018
- Last trade
- 3 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 4 Jun 2026 | KLRS Kalaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | KLRS Kalaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | KLRS Kalaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 18 Mar 2025filed 18 Mar 2025 | KLRS Kalaris TherapeuticsBiotechnology | SEC FORM 4 Code A | —504,000 | filing |
| 26 Jun 2020filed 30 Jun 2020 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,567 at $0.00 | filing |
| 5 Sep 2019filed 9 Sep 2019 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,567 at $0.00 | filing |
| 5 Sep 2019filed 9 Sep 2019 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,433 at $0.00 | filing |
| 30 Apr 2019filed 1 May 2019 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —200,000 at $0.00 | filing |
| 8 Nov 2018filed 13 Nov 2018 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 22 Jun 2018filed 26 Jun 2018 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,514 at $0.00 | filing |
| 22 Jun 2018filed 26 Jun 2018 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
News
Napoleone Ferrara, MD, Receives 2026 Yergin Family International Prize for Biomedical Researchmanilatimes.net · 5 Oct 2026
1 headline in the last 90 days name Napoleone Ferrara; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.